- FDA approves landmark pancreatic cancer drug that's shown to improve survival NPR
- F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer The New York Times
- As RevMed preps for ‘historic’ pancreatic cancer launch, questions linger on the ground Fierce Pharma
- FDA approves once-daily pill for deadly cancer after patients' survival rates nearly double Fox News
- U.S. approves breakthrough pancreatic cancer drug, heralding a new era for an intractable disease Scientific American
Рекомендовані коментарі
Для публікації повідомлень створіть обліковий запис або авторизуйтесь